Tech med and telemedicine
Jeffrey Curtis, MD, MS, MPH
University of Alabama at Birmingham
Hoover, AL, United States
Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); CorEvitas: Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly and Company: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Myriad: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing)
Leila Khalili, MSN, FNP, APRN
Columbia University Medical Center
New York, NY, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Daniel Solomon, MD, MPH
Brigham and Women's Hospital
Newton, MA, United States
Disclosure(s): Janssen: Grant/Research Support (Ongoing)
This session includes results from funded research exploring the use of telemedicine to improve patient care research in individuals with rheumatic diseases. These projects help to answer questions and concepts about tele-rheumatology.
Speaker: Daniel H. Solomon, MD, MPH – Brigham and Women's Hospital
Speaker: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
Speaker: Leila Khalili, MSN, FNP, APRN – Columbia University Medical Center